Targeted Oncology - Immunotherapy, Biomarkers, and Cancer …
Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy for oncologists treating patients in a community setting.
FDA’s December 2024 Oncology Approvals and Designations
Jan 3, 2025 · December 2024 saw notable FDA approvals, including zenocutuzumab (formerly MCLA-128) for NRG1-positive non–small cell lung cancer (NSCLC) and pancreatic cancer, …
Top 10 Breast Cancer Breakthroughs in 2024 - targetedonc.com
Dec 23, 2024 · In 2024, several significant advancements in breast oncology were covered by Targeted Oncology TM. Here are the top 10 developments from the year: FDA Approval of …
FDA Reviews NDA for Dordaviprone in H3K27M-Mutant Diffuse …
Jan 3, 2025 · The FDA is reviewing a new drug application (NDA) for dordaviprone (ONC201), a potential treatment for patients with recurrent H3K27M-mutant diffuse glioma.; Clinical data …
FDA Approves Ensartinib in ALK-Positive NSCLC
Dec 18, 2024 · The FDA has approved ensartinib for the first-line treatment of patients with ALK-positive locally advanced or metastatic NSCLC who have not previously received an ALK …
FDA Approves Subcutaneous Nivolumab Across Existing Solid …
Dec 27, 2024 · The FDA has approved the subcutaneous formulation of nivolumab (Opdivo). This approval makes it the first and only subcutaneously administered PD-1 inhibitor.
GLP-1 Agonists Poised to Impact Breast Cancer Care
Sep 25, 2024 · Recent trends have brought GLP-1 receptor agonists, including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), to front of mind when discussing …
FDA Signals Potential for Standard Approval of Paxalisib in …
Jan 2, 2025 · According to findings from a prespecified secondary analysis of the phase 2/3 GBM AGILE study, paxalisib has shown a meaningful improvement in OS for patients with newly …
AI Tool Enhances Decision-Making in SRS for Brain Metastases
Dec 28, 2024 · A new machine learning tool is transforming decision-making in stereotactic radiosurgery (SRS) for small brain metastases. The tool aims to evaluate factors such as …
CAPOX Regimen Appears Noninferior to FOLFOX in Colorectal …
Oct 8, 2023 · The treatment landscape for patients with resected stage III colon cancer has undergone a significant change, following publication of an International Development and …